<table id="id_afc520e9-0d24-468e-838e-82e95df311b9" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_6008aac6-d6cb-42c6-af75-3cfbd01fdc97">Table 3. Percentage of Ulcers Recurring by 3, 6, and 12 Months in Double-Blind Studies Conducted in the United States</caption>
<col></col>
<col></col>
<col></col>
<tbody>
<tr id="id_aeba4a39-5050-4941-a986-452ad7553156" stylecode="Toprule">
<td align="center" valign="top"> <content stylecode="underline">Month</content>
</td>
<td align="center" stylecode="Toprule" valign="top"> <content stylecode="underline">Nizatidine, 150 mg h.s.</content>
</td>
<td align="center" valign="top"> <content stylecode="underline">Placebo</content>
</td>
</tr>
<tr id="id_bb8402da-ca41-42d7-a72f-84bcf05553a4">
<td align="center" valign="top"> 3</td>
<td align="center" valign="top"> 13% (28/208)<sup>*</sup>
</td>
<td align="center" valign="top"> 40% (82/204)</td>
</tr>
<tr id="id_3f288ec9-4d9b-4461-a1ac-aa3c8d4b7191">
<td align="center" valign="top"> 6</td>
<td align="center" valign="top"> 24% (45/188)<sup>*</sup>
</td>
<td align="center" valign="top"> 57% (106/187)</td>
</tr>
<tr id="id_9a4f633c-6bab-45a0-b387-92fc089a6d0a">
<td align="center" stylecode="Botrule" valign="top"> 12</td>
<td align="center" stylecode="Botrule" valign="top"> 34% (57/166)<sup>*</sup>
</td>
<td align="center" stylecode="Botrule" valign="top"> 64% (112/175)</td>
</tr>
<tr id="id_8a03160c-439b-49ee-b436-7031daff7580" stylecode="Botrule">
<td align="left" colspan="3" valign="top">
<paragraph>
<sup>*</sup> <content stylecode="italics">P</content> &lt;0.001 as compared with placebo. </paragraph>
</td>
</tr>
</tbody>
</table>